📰 Full Story
Multiple entities affiliated with Longitude Capital conducted a sequence of disclosed share sales in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) between Jan. 23 and Feb. 3, 2026.
Filings show combined disposals of roughly 108,739 shares across transactions dated Jan. 23 (7,739 shares), Jan. 30 (46,000), Feb. 2 (27,500) and Feb. 3 (27,500), for gross proceeds of about $474,000.
Despite the sales, Longitude-linked holders continue to hold multimillion-share positions.
Rapid Micro Biosystems, a U.S.-listed life‑sciences equipment company, has recently reported mixed results and remains unprofitable; its most‑recent quarter matched EPS estimates at ($0.26) while revenue metrics have varied in reporting, and analysts carry a consensus “moderate buy” rating with an average target near $8.00.
RPID traded around $4.35 in early February, with a market capitalisation near $193 million and a 52-week range of roughly $1.86–$4.94.


















💬 Commentary